UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression

Medicinal research reviews, 2012-11, Vol.32 (6), p.1220-1262

2012

Volltextzugriff (PDF)

Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies

Medicinal research reviews, 2010-05, Vol.30 (3), p.550-580

2010

Volltextzugriff (PDF)

Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?

International journal of molecular sciences, 2020-10, Vol.21 (21), p.7935

2020

Volltextzugriff (PDF)

Genomic and genetic alterations influence the progression of gastric cancer

World journal of gastroenterology : WJG, 2011-01, Vol.17 (3), p.290-299

2011

Volltextzugriff (PDF)

Establishment and characterization of a new spontaneously immortalized ER−/PR−/HER2+ human breast cancer cell line, DHSF-BR16

Scientific reports, 2021-04, Vol.11 (1), p.8340-8340, Article 8340

2021

Volltextzugriff (PDF)

Some Suggestions from PK/PD Principles to Contain Resistance in the Clinical Setting-Focus on ICU Patients and Gram-Negative Strains

Antibiotics (Basel), 2020-10, Vol.9 (10), p.676

2020

Volltextzugriff (PDF)

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

Translational oncology, 2020-09, Vol.13 (9), p.100795-100795, Article 100795

2020

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

International journal of molecular sciences, 2020-01, Vol.21 (2), p.448

2020

Volltextzugriff (PDF)

Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2010-02, Vol.28 (5), p.866-871

2010

Volltextzugriff (PDF)

Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies

Drug resistance updates, 2011-12, Vol.14 (6), p.280-296

2011

Volltextzugriff (PDF)

Efficacy Evaluation of Plant Products in the Treatment of Erectile Dysfunction Related to Diabetes

Nutrients, 2021-12, Vol.13 (12), p.4520

2021

Volltextzugriff (PDF)

Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action

Frontiers in pharmacology, 2024, Vol.15, p.1362217-1362217

2024

Volltextzugriff (PDF)

Ultramicronized N -palmitoylethanolamine Contributes to Morphine Efficacy Against Neuropathic Pain: Implication of Mast Cells and Glia

Current neuropharmacology, 2024-01, Vol.22 (1), p.88-106

2024

Volltextzugriff (PDF)

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer

Scientific reports, 2020-11, Vol.10 (1), p.19281, Article 19281

2020

Volltextzugriff (PDF)

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study

Current cancer drug targets, 2020-01, Vol.20 (11), p.887-895

2020

Volltextzugriff (PDF)

HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment

PloS one, 2015-12, Vol.10 (12), p.e0144000-e0144000

2015

Volltextzugriff (PDF)

A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma

BMC cancer, 2018-10, Vol.18 (1), p.1024-5, Article 1024

2018

Volltextzugriff (PDF)

Gastrointestinal Cancers and Personalized Medicine

2022

Volltextzugriff (PDF)

A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

Frontiers in pharmacology, 2018-10, Vol.9, p.1101-1101

2018

Volltextzugriff (PDF)

Identification of potential pharmacogenomic markers of clinical efficacy of 5‐fluorouracil in colorectal cancer

International journal of cancer, 2011-04, Vol.128 (8), p.1935-1945

2011

Volltextzugriff (PDF)

2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds

Molecular bioSystems, 2012-01, Vol.8 (4), p.985-993

2012

Volltextzugriff (PDF)

Role of ATP-binding cassette transporters in cancer initiation and progression

Seminars in cancer biology, 2020-02, Vol.60, p.72-95

2020

Volltextzugriff (PDF)

Special Issue: "Gastrointestinal Cancers and Personalized Medicine"

Journal of personalized medicine, 2022-02, Vol.12 (3), p.338

2022

Volltextzugriff (PDF)

Natural compounds for cancer treatment and prevention

Pharmacological research, 2009-06, Vol.59 (6), p.365-378

2009

Volltextzugriff (PDF)

Multidrug resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues

2015

Volltextzugriff (PDF)

1 – 25 von 200

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Englisch
(200)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression

Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies

Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?

Genomic and genetic alterations influence the progression of gastric cancer

Establishment and characterization of a new spontaneously immortalized ER−/PR−/HER2+ human breast cancer cell line, DHSF-BR16

Some Suggestions from PK/PD Principles to Contain Resistance in the Clinical Setting-Focus on ICU Patients and Gram-Negative Strains

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer

Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies

Efficacy Evaluation of Plant Products in the Treatment of Erectile Dysfunction Related to Diabetes

Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action

Ultramicronized N -palmitoylethanolamine Contributes to Morphine Efficacy Against Neuropathic Pain: Implication of Mast Cells and Glia

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study

HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment

A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma

Gastrointestinal Cancers and Personalized Medicine

A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

Identification of potential pharmacogenomic markers of clinical efficacy of 5‐fluorouracil in colorectal cancer

2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds

Role of ATP-binding cassette transporters in cancer initiation and progression

Special Issue: "Gastrointestinal Cancers and Personalized Medicine"

Natural compounds for cancer treatment and prevention

Multidrug resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues

Suchergebnisse filtern